The streptococcal superantigen SMEZ exhibits wide allelic variation, mosaic structure, and significant antigenic variation

Show simple item record

dc.contributor.author Proft, Thomas en
dc.contributor.author Moffatt, Sarah en
dc.contributor.author Weller, KD en
dc.contributor.author Paterson, A en
dc.contributor.author Martin, D en
dc.contributor.author Fraser, John en
dc.date.accessioned 2013-10-02T22:50:29Z en
dc.date.issued 2000 en
dc.identifier.citation Journal of Experimental Medicine 191(10):1765-1776 en
dc.identifier.issn 0022-1007 en
dc.identifier.uri http://hdl.handle.net/2292/20837 en
dc.description.abstract The frequencies of the newly identified streptococcal superantigen genes smez, spe-g, and spe-h were determined in a panel of 103 clinical isolates collected between 1976 and 1998 at various locations throughout New Zealand. smez and spe-g were found in every group A Streptococcus (GAS) isolate, suggesting a chromosomal location. The spe-h gene was found in only 24% of the GAS isolates and is probably located on a mobile DNA element. The smez gene displays extensive allelic variation and appears to be in linkage equilibrium with the M/emm type. 22 novel smez alleles were identified from 21 different M/emm types in addition to the already reported alleles smez and smez-2 with sequence identities between 94. 5 and 99.9%. Three alleles are nonfunctional due to a single base pair deletion. The remaining 21 alleles encode distinct SMEZ variants. The mosaic structure of the smez gene suggests that this polymorphism has arisen from homologous recombination events rather than random point mutation. The recently resolved SMEZ-2 crystal structure shows that the polymorphic residues are mainly surface exposed and scattered over the entire protein. The allelic variation did not affect either Vbeta specificity or potency, but did result in significant antigenic differences. Neutralizing antibody responses of individual human sera against different SMEZ variants varied significantly. 98% of sera completely neutralized SMEZ-1, but only 85% neutralized SMEZ-2, a very potent variant that has not yet been found in any New Zealand isolate. SMEZ-specific Vbeta8 activity was found in culture supernatants of 66% of the GAS isolates, indicating a potential base for the development of a SMEZ targeting vaccine. en
dc.relation.ispartofseries Journal of Experimental Medicine en
dc.rights Items in ResearchSpace are protected by copyright, with all rights reserved, unless otherwise indicated. Previously published items are made available in accordance with the copyright policy of the publisher. Details obtained from http://jcb.rupress.org/content/181/3/405.full http://www.sherpa.ac.uk/romeo/issn/0022-1007/ en
dc.rights.uri https://researchspace.auckland.ac.nz/docs/uoa-docs/rights.htm en
dc.rights.uri http://creativecommons.org/licenses/by-nc-sa/3.0/ en
dc.title The streptococcal superantigen SMEZ exhibits wide allelic variation, mosaic structure, and significant antigenic variation en
dc.type Journal Article en
dc.identifier.doi 10.1084/jem.191.10.1765 en
pubs.issue 10 en
pubs.begin-page 1765 en
pubs.volume 191 en
dc.identifier.pmid 10811869 en
pubs.author-url http://www.jem.org/cgi/current/full/191/10/1765 en
pubs.end-page 1776 en
dc.rights.accessrights http://purl.org/eprint/accessRights/RestrictedAccess en
pubs.subtype Article en
pubs.elements-id 2599 en
pubs.org-id Medical and Health Sciences en
pubs.org-id Medical Sciences en
pubs.org-id Molecular Medicine en
pubs.org-id School of Medicine en
pubs.org-id Ophthalmology Department en
pubs.org-id Science en
pubs.org-id Science Research en
pubs.org-id Maurice Wilkins Centre (2010-2014) en
dc.identifier.eissn 1540-9538 en
pubs.record-created-at-source-date 2010-09-01 en
pubs.dimensions-id 10811869 en


Files in this item

Find Full text

This item appears in the following Collection(s)

Show simple item record

Share

Search ResearchSpace


Browse

Statistics